{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$4.79 vs. cons $4.71",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Index operating revenue",
      "prediction": "BEAT",
      "answer": "pred ~$509M vs. cons $503M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net new recurring subscription sales",
      "prediction": "BEAT",
      "answer": "pred ~$45.5M vs. cons $44.0M",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Free cash flow guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$1.50B vs. cons $1.50B (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Adjusted EBITDA expense guidance / top-half positioning",
      "prediction": "BETTER",
      "answer": "guide ~$1.32B vs. cons $1.33B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Analytics revenue-growth commentary",
      "prediction": "UNCHANGED",
      "answer": "guide ~5.0% vs. cons 5.0% (2Q2026)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 2.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.5,
  "day5_path": "FADE",
  "day5_rationale": "The initial ~2.0% residual gain should fade toward ~0.5% over five days because an EPS/sales beat is likely to be offset by FY2026 FCF guidance of ~$1.50B versus ~$1.50B consensus and only modest FY2027 estimate upside.",
  "day5_confidence": "MEDIUM"
}